The nurse will plan to teach a patient with Crohn's disease who has megaloblastic anemia about the need for:

Choice A reason: Determining insurance coverage is a logistical concern related to medication adherence and healthcare access. While important for ensuring the client can obtain the treatment, it is not a clinical priority or a safety screening question required before the administration of a potentially high-risk pharmacological agent.

Choice B reason: Sulfasalazine is a compound of 5-aminosalicylic acid and sulfapyridine. It is contraindicated in patients with known hypersensitivity to sulfonamides or salicylates. Asking about allergies is the highest priority to prevent life-threatening Type 1 hypersensitivity reactions, such as anaphylaxis, or severe cutaneous adverse reactions like Stevens-Johnson syndrome.

Choice C reason: Inquiring about vitamins is relevant because sulfasalazine can interfere with the absorption of folic acid (Vitamin B9), often requiring supplementation. However, this is a secondary management concern. The immediate safety priority is screening for allergies that could cause an acute, severe systemic reaction upon the first dose.

Choice D reason: Assessing the ability to swallow pills is a practical consideration for oral medication administration. If a patient has dysphagia, the nurse might need an alternative formulation. However, this does not carry the same clinical weight as screening for a drug allergy that could lead to significant medical morbidity.

Choice A reason: Immobilization of the arm for 4 to 6 days is contraindicated following the creation of an arteriovenous (AV) fistula. While the incision site must be protected, gentle exercise of the arm, such as squeezing a rubber ball, is actually encouraged to increase blood flow and promote the "maturation" or thickening of the vessel walls.

Choice B reason: An AV fistula is created by a surgical anastomosis between an artery (typically the radial or brachial artery) and a vein (typically the cephalic vein). This allows high-pressure arterial blood to flow directly into the vein, causing the vein to dilate and become tough enough to withstand repeated large-bore needle cannulations.

Choice C reason: Hemodialysis requires two needles to be inserted into the fistula for each treatment, not one. One needle (the arterial needle) withdraws blood from the body to be sent to the dialyzer for cleaning, while the second needle (the venous needle) returns the filtered blood back to the patient's circulation.

Choice D reason: An AV fistula cannot be used 5 to 7 days after surgery. It requires a significant "maturation" period, usually lasting 2 to 4 months, before it is ready for use. Using it too early can cause the vessel to collapse or infiltrate. If urgent dialysis is needed, a temporary central venous catheter is used in the interim.